Vincenzo Mitchell Barroso

Vincenzo Mitchell Barroso

Auto-generated profile, based on publicly available information

Vincenzo Mitchell Barroso

Institute of Pathology, University Hospital of Cologne and Medical Faculty, Cologne, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2025 in Clinical Cancer Research
Verified
Journal Article
Closed access
KNKa-Won Noh
Ka-Won Noh
YTYuri Tolkach
Yuri Tolkach
DHDoris Helbig
Doris Helbig
VBVincenzo Mitchell Barroso
Vincenzo Mitchell Barroso
YFYannick Foerster
Yannick Foerster
OPOana-Diana Persa
Oana-Diana Persa
Purpose: Treatment with immune checkpoint inhibitors (ICI) in advanced melanoma can result in durable responses, yet an algorithm to decide which patients can safely discontinue ICI is still lacking. Experimental Design: We used a multimodal approach combining clinical data, artificial intelligence–based analysis of hematoxylin and eosin–stained whole-slide images of melanoma before ICI start, and gene expression signatures to identify biomarkers for relapse after discontinuing ICI in the absence of treatment progression. Results: Univariable Cox regression analysis identified the best overall response, mRNA expression of six genes, tumor cell density, and the lymphocyte-to-plasma cell ratio as factors predictive of relapse upon the cessation of the ICI. Multivariable Cox regression analysis showed that both TGFBR1 expression and the integral digital pathology parameter–based prognostic system were independently associated with relapse after ICI discontinuation. Training a multivariate adaptive regression spline model achieved the highest overall predictive accuracy of 84.6% for relapse after ICI discontinuation. Conclusions: The identified prognostic markers are fully explainable and easily implementable in routine practice, facilitating risk stratification upon the cessation of ICI therapy.

14 November 2025
Verified
Other
Open access
KNKa-Won Noh
Ka-Won Noh
YTYuri Tolkach
Yuri Tolkach
DHDoris Helbig
Doris Helbig
VBVincenzo Mitchell Barroso
Vincenzo Mitchell Barroso
YFYannick Foerster
Yannick Foerster
OPOana-Diana Persa
Oana-Diana Persa
Pair-wise associations between best overall survival (stable disease) and other variables in the multivariable Cox model

14 November 2025
Verified
Other
Open access
KNKa-Won Noh
Ka-Won Noh
YTYuri Tolkach
Yuri Tolkach
DHDoris Helbig
Doris Helbig
VBVincenzo Mitchell Barroso
Vincenzo Mitchell Barroso
YFYannick Foerster
Yannick Foerster
OPOana-Diana Persa
Oana-Diana Persa
Flow chart with an overview of patients included in the study

14 November 2025
Verified
Other
Open access
KNKa-Won Noh
Ka-Won Noh
YTYuri Tolkach
Yuri Tolkach
DHDoris Helbig
Doris Helbig
VBVincenzo Mitchell Barroso
Vincenzo Mitchell Barroso
YFYannick Foerster
Yannick Foerster
OPOana-Diana Persa
Oana-Diana Persa
Univariable Cox regression analysis of factors contributing to progression in the cessation cohort.

14 November 2025
Verified
Other
Open access
KNKa-Won Noh
Ka-Won Noh
YTYuri Tolkach
Yuri Tolkach
DHDoris Helbig
Doris Helbig
VBVincenzo Mitchell Barroso
Vincenzo Mitchell Barroso
YFYannick Foerster
Yannick Foerster
OPOana-Diana Persa
Oana-Diana Persa
Summary of clinical data and results of AI analysis of whole-slide image.

14 November 2025
Verified
Other
Open access
KNKa-Won Noh
Ka-Won Noh
YTYuri Tolkach
Yuri Tolkach
DHDoris Helbig
Doris Helbig
VBVincenzo Mitchell Barroso
Vincenzo Mitchell Barroso
YFYannick Foerster
Yannick Foerster
OPOana-Diana Persa
Oana-Diana Persa
Cutoff values used to stratify patients